Vetoquinol: Sales for 1st Quarter 2026

About this update from Vetoquinol Sa

[{"type":"text","content":"Sales: €125 million -0.3% at constant exchange rates","length":52,"tagName":"p"},{"type":"text","content":"LURE, France, April 28, 2026--(BUSINESS WIRE)--Regulatory News:","length":63,"tagName":"p"},{"type":"text","content":"Vetoquinol (Paris:VETO):","length":24,"tagName":"p"},{"type":"text","content":"Sales for the first quarter of 2026 amounted to €125 million, down 4.3% on a reported basis, flat (-0.3%) at constant exchange rates and up 1.2% compared to the previous year at constant exchange rates and excluding the complementary product line simplification program.","length":270,"tagName":"p"},{"type":"text","content":"The impact of exchange rates was historically high during the first quarter, reaching -€5.2 million, primarily in the United States (-€2.9 million) and India (-€1.5 million). The program to simplify complementary product lines, which continues through 2026, impacted sales by €1.7 million. Excluding these two effects, sales increased by 1.2% compared to the previous year.","length":373,"tagName":"p"},{"type":"text","content":"Sales from Essential products, at €83 million, were stable at constant exchange rates compared to the previous year, while sales from complementary products, excluding the simplification program and at constant exchange rates, increased by 3%, driven by a solid performance in the U.S. In the 1st quarter of 2026, sales of Essential products accounted for 66.3% of the company’s sales, compared to 65.0% in the first quarter of 2025.","length":433,"tagName":"p"},{"type":"text","content":"Business in the United States confirmed its rebound in the 1st quarter. Sales rose 15.6% at constant exchange rates to €28 million. Sales in Europe totaled €65 million; sales in the Americas excluding the United States at €17 million, and sales in Asia/Pacific at €20 million, both at constant exchange rates. Sales of products for companion animals totaled €93 million, representing 71% of sales, and sales of products for farm animals totaled €38 million, at constant exchange rates.","length":485,"tagName":"p"},{"type":"text","content":"Sales for the first quarter of 2026 have not been audited by the Statutory Auditors.","length":84,"tagName":"p"},{"type":"text","content":"Excluding the impact of a highly unstable geopolitical environment, 2026 will be a transition year in terms of business activity, marked by a ...

More updates from Vetoquinol Sa